nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach
|
Piena, Marjanne A. |
|
|
39 |
2 |
p. 892-908 |
artikel |
2 |
Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data
|
Yoshida, Manami |
|
|
39 |
2 |
p. 992-1003 |
artikel |
3 |
Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan
|
Chen, Kuan-Yuan |
|
|
39 |
2 |
p. 910-922 |
artikel |
4 |
Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach
|
Piena, Marjanne A. |
|
|
39 |
2 |
p. 909 |
artikel |
5 |
Correction to: Asthma and Chronic Obstructive Pulmonary Disease Overlap According to the Japanese Respiratory Society Diagnostic Criteria: The Prospective, Observational ACO Japan Cohort Study
|
Hashimoto, Shu |
|
|
39 |
2 |
p. 1096-1099 |
artikel |
6 |
Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study
|
Sarkar, Gouranga |
|
|
39 |
2 |
p. 923-942 |
artikel |
7 |
Individualized HbA1c Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey
|
Lautsch, Dominik |
|
|
39 |
2 |
p. 1016-1032 |
artikel |
8 |
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR
|
Frankel, Jeffrey |
|
|
39 |
2 |
p. 959-970 |
artikel |
9 |
Measuring Burden of Illness in Phenylketonuria (PKU): Development of the PKU Symptom Severity and Impacts Scale as a Robust Patient-Reported Outcome
|
Quinn, Jennifer |
|
|
39 |
2 |
p. 971-991 |
artikel |
10 |
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
|
Kreuter, Michael |
|
|
39 |
2 |
p. 1081-1095 |
artikel |
11 |
Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study
|
Ghislain, Pierre-Dominique |
|
|
39 |
2 |
p. 1068-1080 |
artikel |
12 |
Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO Study
|
de Vlam, Kurt |
|
|
39 |
2 |
p. 1055-1067 |
artikel |
13 |
Real-World Management of Hyperkalemia in the Emergency Department: An Electronic Medical Record Analysis
|
Davis, Jill |
|
|
39 |
2 |
p. 1033-1044 |
artikel |
14 |
Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence
|
Wang, Yongmei |
|
|
39 |
2 |
p. 862-891 |
artikel |
15 |
The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United States
|
Sieluk, Jan |
|
|
39 |
2 |
p. 943-958 |
artikel |
16 |
The Epidemiology of Persons Living with Fontan in 2020 and Projections for 2030: Development of an Epidemiology Model Providing Multinational Estimates
|
Plappert, Leandra |
|
|
39 |
2 |
p. 1004-1015 |
artikel |
17 |
Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review
|
Rao, Shaline |
|
|
39 |
2 |
p. 845-861 |
artikel |
18 |
Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework
|
Langford, Bryony |
|
|
39 |
2 |
p. 1045-1054 |
artikel |
19 |
White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example
|
Jackisch, Christian |
|
|
39 |
2 |
p. 833-844 |
artikel |